Med.-Polonia Sp. z o.o. NSZOZ

Poznan 60-693

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early
• A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy — Completed